{"denoms":[{"counts":[{"groupId":"BG000","value":"0"}],"units":"Participants"}],"groups":[{"description":"Induction: DPACE(dexamethasone,cisplatin,doxorubicin,cyclophosphamide,etoposide) chemotherapy plus stem cell collection. Additional stem cell collection and/or chemotherapy may be required.\n\nAfter collection, participants will receive dexamethasone x 4 days every 14 days.","id":"BG000","title":"Tandem Autologous Stem Cell Transplant"}],"measures":[{"classes":[{"categories":[{"title":"<=18 years"},{"title":"Between 18 and 65 years"},{"title":">=65 years"}]}],"title":"Age, Categorical"},{"title":"Age, Continuous"},{"classes":[{"categories":[{"title":"Female"},{"title":"Male"}]}],"title":"Sex: Female, Male"},{"classes":[{"title":"United States"}],"title":"Region of Enrollment","unitOfMeasure":"participants"}],"populationDescription":"Data not available. Study conducted at University of Utah. Upon PI leaving Utah and coming to the University of Iowa, record NCT00670631 was transferred to Iowa by ClinicalTrials.gov staff. No research activities under NCT00670631 were conducted at Iowa. PRS staff at Iowa and Utah have corresponded and neither party (including PI) have the data."}